Annals of Clinical Psychiatry最新文献

筛选
英文 中文
Paula Jean Winkler Clayton, MD (1934-2021). Paula Jean Winkler Clayton,医学博士(1934-2021)。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01 DOI: 10.12788/acp.0057
C. Rich, L. Cunningham
{"title":"Paula Jean Winkler Clayton, MD (1934-2021).","authors":"C. Rich, L. Cunningham","doi":"10.12788/acp.0057","DOIUrl":"https://doi.org/10.12788/acp.0057","url":null,"abstract":"","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":"1 1","pages":"5-6"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90626048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of and reasons for electronic cigarette use among adult smokers with schizophrenia/schizoaffective disorder. 精神分裂症/分裂情感性障碍成年吸烟者使用电子烟的特点及原因
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01 DOI: 10.12788/acp.0050
Jordan A Wong, Sarah I Pratt, Joelle C Ferron, Minda Gowarty, Mary F Brunette
{"title":"Characteristics of and reasons for electronic cigarette use among adult smokers with schizophrenia/schizoaffective disorder.","authors":"Jordan A Wong,&nbsp;Sarah I Pratt,&nbsp;Joelle C Ferron,&nbsp;Minda Gowarty,&nbsp;Mary F Brunette","doi":"10.12788/acp.0050","DOIUrl":"https://doi.org/10.12788/acp.0050","url":null,"abstract":"<p><strong>Background: </strong>The objective of our study was to determine lifetime and current e-cigarette use among adult cigarette smokers with schizophrenia or schizoaffective disorder, and to describe characteristics of these e-cigarette users.</p><p><strong>Methods: </strong>Adult daily tobacco smokers with schizophrenia who were psychiatrically stable in outpatient treatment (n = 162) were enrolled in a motivational intervention study from 2013 to 2015 and followed for 6 months. Approximately 80% (n = 140) completed a 6-month follow-up, including the Population Assessment of Tobacco and Health survey.</p><p><strong>Results: </strong>Among the 140 participants, 46% (n = 64) reported ever using e-cigarettes and 15% (n = 21) reported current use. Participants were significantly more likely to report ever-use if they were younger (Chi-square = 11.7, P < .01), lesbian/gay/bisexual (LGB) (Chi-square = 4.8, P = .03), or reported recent drug use (Chi-square = 6.5, P = .01). In a multivariate model, only age remained a significant predictor of ever-use (coefficient: 0.03; P = .02). The most common reasons for using e-cigarettes were \"helps people quit cigarettes\" and \"less harmful to me or to people around me than cigarettes.\" Current e-cigarette users had significantly lower carbon monoxide levels than past e-cigarettes users (T = 2.08, P = .04).</p><p><strong>Conclusions: </strong>Almost one-half of smokers with schizophrenia or schizoaffective disorder reported ever using e-cigarettes. Interventions for tobacco use among this demographic should incorporate recognition of e-cigarette use, particularly among younger adults, illicit drug users, and LGB individuals.</p>","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":" ","pages":"89-96"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39632127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Demise of a physician. 一位医生的死亡。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01 DOI: 10.12788/acp.0058
Richard Balon, Mary K Morreale
{"title":"Demise of a physician.","authors":"Richard Balon,&nbsp;Mary K Morreale","doi":"10.12788/acp.0058","DOIUrl":"https://doi.org/10.12788/acp.0058","url":null,"abstract":"","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":" ","pages":"1-3"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39801268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A pilot study on predictors of length of stay in a geriatric psychiatric hospital. 老年精神病院住院时间预测因素的初步研究。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01 DOI: 10.12788/acp.0051
Obiora Onwuameze, Nana Cudjoe, Sumi Rebeiro, Dolapo Oseni, Steve Ippolito, Albert Botchway, Vinod Alluri, Kristin Lee
{"title":"A pilot study on predictors of length of stay in a geriatric psychiatric hospital.","authors":"Obiora Onwuameze,&nbsp;Nana Cudjoe,&nbsp;Sumi Rebeiro,&nbsp;Dolapo Oseni,&nbsp;Steve Ippolito,&nbsp;Albert Botchway,&nbsp;Vinod Alluri,&nbsp;Kristin Lee","doi":"10.12788/acp.0051","DOIUrl":"https://doi.org/10.12788/acp.0051","url":null,"abstract":"<p><strong>Background: </strong>We wanted to determine the factors that influence geriatric psychiatric hospitalization length of stay (LOS).</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of a sample of hospital admission records from 2012 to 2018. The hospital records were the geriatric inpatient records of St. John's Hospital, Springfield, Illinois. The data collection was based on the inclusion criteria as approved by the Southern Illinois University School of Medicine Institutional Review Board. To be eligible, participants had to have at least 1 inpatient hospitalization between 2012 and 2017. For the purposes of this study, psychiatric diagnosis was based on DSM-IV criteria.</p><p><strong>Results: </strong>The 141 participants' average age was 71.7 years, and approximately 57% were female; average length of stay was 16 days (range: 1 to 116 days). Indications for current admission included depression and suicidal ideation (45%), psychosis (30%), psychosis and agitation (22%), and mania (3%). Results indicate that having a major depressive disorder (MDD) diagnosis (vs bipolar disorder and schizophrenia) was significantly associated with shorter LOS (P < .001). Other significant predictors were psychosis (P = .03), using mood stabilizers (P = .02), using antidepressants (P = .05), and use of ≥2 (vs 1 or 0) psychotropic medications (P = .02).</p><p><strong>Conclusions: </strong>Geriatric psychiatric hospitalization was longer in patients with psychosis, but shorter for patients with MDD. Patients receiving mood stabilizers, as well as those receiving ≥2 psychotropics, had longer LOS, while those receiving antidepressants had shorter LOS. This highlights the idea that patients with serious mental illnesses may have longer LOS.</p>","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":" ","pages":"21-26"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39801270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatry Update Winter Abstract Compendium 精神病学冬季更新摘要纲要
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01
{"title":"Psychiatry Update Winter Abstract Compendium","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":"34 1S","pages":"1-8"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39925518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visage mauve secondary to chlorpromazine. 淡紫色,次级氯丙嗪。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01 DOI: 10.12788/acp.0054
Andrew M Poggemiller, Anthony Berger, Erin M Crocker, Jennifer G Powers
{"title":"Visage mauve secondary to chlorpromazine.","authors":"Andrew M Poggemiller,&nbsp;Anthony Berger,&nbsp;Erin M Crocker,&nbsp;Jennifer G Powers","doi":"10.12788/acp.0054","DOIUrl":"https://doi.org/10.12788/acp.0054","url":null,"abstract":"","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":" ","pages":"59-60"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39632124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress. 氯胺酮治疗情绪障碍和自杀:近期进展的叙述性回顾。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2022-02-01 DOI: 10.12788/acp.0048
Michael D Kritzer, Nicholas A Mischel, Jonathan R Young, Christopher S Lai, Prakash S Masand, Steven T Szabo, Sanjay J Mathew
{"title":"Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress.","authors":"Michael D Kritzer,&nbsp;Nicholas A Mischel,&nbsp;Jonathan R Young,&nbsp;Christopher S Lai,&nbsp;Prakash S Masand,&nbsp;Steven T Szabo,&nbsp;Sanjay J Mathew","doi":"10.12788/acp.0048","DOIUrl":"https://doi.org/10.12788/acp.0048","url":null,"abstract":"<p><strong>Background: </strong>Mood disorders are a leading cause of morbidity. Many patients experience treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting and more effective antidepressant medications are needed. Four decades of research has transformed the use of ketamine from an anesthetic to an outpatient treatment for major depressive disorder (MDD). Ketamine is a N-methyl-d-aspartate (NMDA) receptor antagonist and has been shown to rapidly improve mood symptoms and suicidal ideation by targeting the glutamate system directly.</p><p><strong>Methods: </strong>We used the PubMed database to identify relevant articles published until September 1, 2020. We focused on meta-analyses, randomized controlled trials, and original observational studies. We included relevant studies for depression, MDD, TRD, bipolar disorder, anxiety, posttraumatic stress disorder (PTSD), suicide, ketamine, and esketamine.</p><p><strong>Results: </strong>Both racemic ketamine and esketamine have been shown to rapidly treat depression and suicidality. There is evidence that ketamine can be helpful for anxiety and PTSD; however, more research is needed. Intranasal esketamine has been FDA approved to treat depression.</p><p><strong>Conclusions: </strong>This narrative review describes the evolution of ketamine to treat mood disorders and suicidality. We provide the evidence supporting recent developments using esketamine as well as unresolved issues in the field, such as dosing and safety.</p>","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":" ","pages":"33-43"},"PeriodicalIF":1.3,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044467/pdf/nihms-1796552.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39632125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Psychotherapy for personality disorders is underfunded. 人格障碍的心理治疗资金不足。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2021-11-01 DOI: 10.12788/acp.0043
Joel Paris, Donald W Black
{"title":"Psychotherapy for personality disorders is underfunded.","authors":"Joel Paris,&nbsp;Donald W Black","doi":"10.12788/acp.0043","DOIUrl":"https://doi.org/10.12788/acp.0043","url":null,"abstract":"","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":"33 4","pages":"217-218"},"PeriodicalIF":1.3,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39536196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Artificial intelligence to aid detection and diagnostic accuracy of mood disorders and predict suicide risk: A systematic review. 人工智能有助于情绪障碍的检测和诊断准确性,并预测自杀风险:系统综述。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2021-11-01 DOI: 10.12788/acp.0041
Sahithi Edavally, D Doug Miller, Nagy A Youssef
{"title":"Artificial intelligence to aid detection and diagnostic accuracy of mood disorders and predict suicide risk: A systematic review.","authors":"Sahithi Edavally,&nbsp;D Doug Miller,&nbsp;Nagy A Youssef","doi":"10.12788/acp.0041","DOIUrl":"https://doi.org/10.12788/acp.0041","url":null,"abstract":"<p><strong>Background: </strong>Mood disorders often are diagnosed by clinical interview, yet many cases are missed or misdiagnosed. Mood disorders increase the risk of suicide, making it imperative to diagnose and treat these disorders quickly. Artificial intelligence (AI) has been investigated for diagnosing mood disorders, but the merits of the literature have not been evaluated. This systematic review aims to understand and explain AI methods and evaluate their use in augmenting clinical diagnosis of mood disorders as well as identifying individuals at increased suicide risk.</p><p><strong>Methods: </strong>We conducted a systematic literature review of all studies until August 1, 2020 examining the efficacy of different AI techniques for diagnosing mood disorders and identifying individuals at increased suicide risk because of a mood disorder.</p><p><strong>Results: </strong>Our literature search generated 13 studies (10 of mood disorders and 3 describing suicide risk) where AI techniques were used. Machine learning and artificial neural networks were most commonly used; both showed merit in helping to diagnose mood disorders and assess suicide risk.</p><p><strong>Conclusions: </strong>The data shows that AI methods have merit in improving the diagnosis of mood disorders as well as identifying suicide risk. More research is needed for bipolar disorder because only 2 studies explored this condition, and it is often misdiagnosed. Although only a few AI techniques are discussed in detail in this review, there are many more that can be employed, and should be evaluated in future studies.</p>","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":"33 4","pages":"270-281"},"PeriodicalIF":1.3,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39536564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Psychometric properties of the Generalized Anxiety Disorder 7-item scale in youth: Screening in a primary care sample. 青少年广泛性焦虑障碍7项量表的心理测量特征:初级保健样本的筛选。
IF 1.3 4区 医学
Annals of Clinical Psychiatry Pub Date : 2021-11-01 DOI: 10.12788/acp.0047
Jennifer L Hughes, Bruce D Grannemann, Joseph M Trombello, W Blake Martin, Anne K Fuller, Madhukar H Trivedi
{"title":"Psychometric properties of the Generalized Anxiety Disorder 7-item scale in youth: Screening in a primary care sample.","authors":"Jennifer L Hughes,&nbsp;Bruce D Grannemann,&nbsp;Joseph M Trombello,&nbsp;W Blake Martin,&nbsp;Anne K Fuller,&nbsp;Madhukar H Trivedi","doi":"10.12788/acp.0047","DOIUrl":"https://doi.org/10.12788/acp.0047","url":null,"abstract":"<p><strong>Background: </strong>Anxiety disorders in youth are frequently underdiagnosed and untreated, partly due to a lack of screening in primary care. The Generalized Anxiety Disorder 7-item (GAD-7) scale is a brief self-report measure designed to screen for anxiety in primary care settings. However, little is known about the psychometrics of this scale with adolescents.</p><p><strong>Methods: </strong>Participants included 579 youth age 11 to 17 years who received screening for depression in a primary care setting through a web-based application, VitalSign<sup>6</sup>, over a 4-year period. Psychometric analyses were completed based on classical test theory (CTT) and item response theory (IRT).</p><p><strong>Results: </strong>Using CTT and IRT methods, the GAD-7 has a unidimensional structure with good psychometric properties. In addition, the IRT analysis demonstrates that items 1 and 2 are strongly associated with the total score, and thus are good choices as a 2-item screening tool. Convergent validity was demonstrated, with high correlations between the GAD-7 and other measures of anxiety, and discriminant validity was also demonstrated, with low correlations to measures of other psychological states.</p><p><strong>Conclusions: </strong>This psychometric evaluation of the GAD-7 provides support for the utility of this measure with adolescents. The GAD-2 is a good estimate of GAD-7 total score.</p>","PeriodicalId":50770,"journal":{"name":"Annals of Clinical Psychiatry","volume":"33 4","pages":"241-250"},"PeriodicalIF":1.3,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39536198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信